Combination chemotherapy including epirubicin for the management of non-Hodgkin's lymphoma
- 1 September 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (9), 1379-1384
- https://doi.org/10.1016/0277-5379(87)90123-4
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Non-Hodgkin's Lymphoma: Management StrategiesNew England Journal of Medicine, 1984
- 4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical dataCancer Treatment Reviews, 1983
- National cancer institute sponsored study of classifications of non-hodgkin's lymphomas. Summary and description of a working formulation for clinical usageCancer, 1982
- Systolic time interval as index of schedule--dependent doxorubicin cardiotoxicity in patients with acute myelogenous leukaemia.BMJ, 1979
- Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type.BMJ, 1978
- Hydroxyldaunomycin (adriamycin) combination chemotherapy in malignant lymphomaCancer, 1976
- Treatment of advanced non-Hodgkin's lymphomas with favorable histologies: preliminary results of a prospective trialBlood, 1976
- The Histopathology of Malignant LymphomaBritish Journal of Haematology, 1975
- ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA, A POTENTIALLY CURABLE DISEASEThe Lancet, 1975
- Bedside technics for the evaluation of ventricular function in manThe American Journal of Cardiology, 1969